|
Transplantation
Citations 421-430 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection
- Espen Ø. Kvale, Jakob Dalgaard, Fridtjof Lund-Johansen, Halvor Rollag, Lorant Farkas, Karsten Midtvedt, Frode L. Jahnsen, Jan E. Brinchmann, and Johanna Olweus
Blood 2006; 107: 2022-2029.
[Abstract]
[Full text]
[PDF]
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model
- Barry J. Kappel, Javier Pinilla-Ibarz, Adam A. Kochman, Jeffrey M. Eng, Vanessa M. Hubbard, Ingrid Leiner, Eric G. Pamer, Glen Heller, Marcel R. M. van den Brink, and David A. Scheinberg
Blood 2006; 107: 2045-2051.
[Abstract]
[Full text]
[PDF]
131I–anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission
- John M. Pagel, Frederick R. Appelbaum, Janet F. Eary, Joseph Rajendran, Darrell R. Fisher, Ted Gooley, Katherine Ruffner, Eneida Nemecek, Eileen Sickle, Larry Durack, Jeanette Carreras, Mary M. Horowitz, Oliver W. Press, Ajay K. Gopal, Paul J. Martin, Irwin D. Bernstein, and Dana C. Matthews
Blood 2006; 107: 2184-2191.
[Abstract]
[Full text]
[PDF]
G-CSF–treated granulocytes inhibit acute graft-versus-host disease
- Zilton F. M. Vasconcelos, Bruna M. dos Santos, Julia Farache, Tereza S. S. Palmeira, Rômulo B. Areal, José Marcos T. Cunha, Marcello A. Barcinski, and Adriana Bonomo
Blood 2006; 107: 2192-2199.
[Abstract]
[Full text]
[PDF]
Genetic variation in bactericidal/permeability-increasing protein influences the risk of developing rapid airflow decline after hematopoietic cell transplantation
- Jason W. Chien, Lue Ping Zhao, John A. Hansen, Wen Hong Fan, Tanyalak Parimon, and Joan G. Clark
Blood 2006; 107: 2200-2207.
[Abstract]
[Full text]
[PDF]
T-cell non-Hodgkin lymphoma
- Mujahid A. Rizvi, Andrew M. Evens, Martin S. Tallman, Beverly P. Nelson, and Steven T. Rosen
Blood 2006; 107: 1255-1264.
[Abstract]
[Full text]
[PDF]
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation
- David L. Porter, Bruce L. Levine, Nancy Bunin, Edward A. Stadtmauer, Selina M. Luger, Steven Goldstein, Alison Loren, Julie Phillips, Sunita Nasta, Alexander Perl, Steven Schuster, Donald Tsai, Ambika Sohal, Elizabeth Veloso, Stephen Emerson, and Carl H. June
Blood 2006; 107: 1325-1331.
[Abstract]
[Full text]
[PDF]
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation
- Raphaël F. Rousseau, Ettore Biagi, Aurélie Dutour, Eric S. Yvon, Michael P. Brown, Tiffany Lin, Zhuyong Mei, Bambi Grilley, Edwina Popek, Helen E. Heslop, Adrian P. Gee, Robert A. Krance, Uday Popat, George Carrum, Judith F. Margolin, and Malcolm K. Brenner
Blood 2006; 107: 1332-1341.
[Abstract]
[Full text]
[PDF]
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
- Barbara Zemann, Bernd Kinzel, Matthias Müller, Roland Reuschel, Diana Mechtcheriakova, Nicole Urtz, Frédéric Bornancin, Thomas Baumruker, and Andreas Billich
Blood 2006; 107: 1454-1458.
[Abstract]
[Full text]
[PDF]
Regulation of ITAM-positive receptors: role of IL-12 and IL-18
- John R. Ortaldo, Robin Winkler-Pickett, Jon Wigginton, Meagan Horner, Earl W. Bere, Anna T. Mason, Narayan Bhat, James Cherry, Michael Sanford, Deborah L. Hodge, and Howard A. Young
Blood 2006; 107: 1468-1475.
[Abstract]
[Full text]
[PDF]
|
|
